Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other solid neoplasm 25Breast 21Gastrointestinal 19Genitourinary 18Tumor-Agnostic 13Gynecologic 13Thoracic 12Other hematologic neoplasm 10Head & Neck 10Lymphoid 6Plasma cell 5Other 4Sarcoma 3Other neoplasm 2Endocrine 2Dermatologic 2CNS 2

Conditions

Thyroid Cancer, Papillary 2Adenocarcinoma, Follicular 2Testicular Neoplasms 1Melanoma 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Interviews as Topic × Endocrine × Clear all
NCT07545837 2026-04-27

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Mayo Clinic

Phase NA Not yet recruiting
20 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡